Literature DB >> 16723786

Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.

Kunihiko Kameda1, Toshiro Matsunaga, Naoki Abe, Takayuki Fujiwara, Hiroyuki Hanada, Kozo Fukui, Ikuo Fukuda, Tomohiro Osanai, Ken Okumura.   

Abstract

BACKGROUND: In an animal model of acute myocardial infarction (AMI), deletion of matrix metalloproteinase (MMP)-9 results in suppression of the development of cardiac rupture. The present study sought to clarify how myocardial MMP-9 activity is related to the pathophysiologies of AMI and cardiac rupture in humans. METHODS AND
RESULTS: Levels of interleukin-8 (IL-8), polymorphonuclear leukocyte (PMN) elastase, monocyte chemotactic protein-1 (MCP-1) and MMP activity were measured in the pericardial fluid obtained from 28 patients with angina pectoris (AP group) and 16 patients with AMI (AMI group) undergoing cardiac surgery. In the AMI group, 5 were complicated with ventricular septal perforation (VSP) and the remaining 11 were not (non-VSP). Levels of IL-8, PMN elastase, MMP-2 and MMP-9 activity were all higher in the AMI group than in the AP group. In the AMI group, all levels other than MMP-2 activity were further elevated in cases with VSP compared with those in the non-VSP group. There was no significant difference in MCP-1 among the groups
CONCLUSIONS: Markers of neutrophil activation in the infarcted cardiac tissue seem to be elevated in AMI. Highly elevated levels of MMP-9 activity, which may be derived from neutrophils, and PMN elastase may be related to the pathophysiology of VSP or cardiac rupture in AMI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723786     DOI: 10.1253/circj.70.673

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.

Authors:  Takashi Yokota; Tomohiro Osanai; Kenji Hanada; Motoi Kushibiki; Naoki Abe; Koichi Oikawa; Hirofumi Tomita; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Ken Okumura
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.

Authors:  Sherin Ali Nawaito; Pramod Sahadevan; Marie-Élaine Clavet-Lanthier; Philippe Pouliot; Fatiha Sahmi; Yanfen Shi; Marc-Antoine Gillis; Frederic Lesage; Matthias Gaestel; Martin G Sirois; Angelo Calderone; Jean-Claude Tardif; Bruce G Allen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-22       Impact factor: 4.733

3.  N-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice.

Authors:  Hongmei Peng; Jiang Xu; Xiao-Ping Yang; Kamal M Kassem; Imane A Rhaleb; Ed Peterson; Nour-Eddine Rhaleb
Journal:  Can J Physiol Pharmacol       Date:  2019-04-18       Impact factor: 2.273

4.  Risk of cardiac rupture after acute myocardial infarction is related to a risk of hemorrhage.

Authors:  Geng Qian; Hong-bin Liu; Jin-wen Wang; Chen Wu; Yun-dai Chen
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

5.  Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.

Authors:  Hongmei Peng; Jiang Xu; Xiao-Ping Yang; Xiangguo Dai; Edward L Peterson; Oscar A Carretero; Nour-Eddine Rhaleb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

6.  Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarction.

Authors:  Savas Guzel; Ozden Serin; Eda Celik Guzel; Banu Buyuk; Güzin Yılmaz; Guvenc Güvenen
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

7.  Role of monocyte chemoattractant protein-1 in myocardial infarction.

Authors:  Hajime Morimoto; Masafumi Takahashi
Journal:  Int J Biomed Sci       Date:  2007-09

8.  Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery.

Authors:  Yves Denizot; Alexandre Leguyader; Elisabeth Cornu; Marc Laskar; Isabelle Orsel; Christelle Vincent; Nathalie Nathan
Journal:  J Cardiothorac Surg       Date:  2007-09-21       Impact factor: 1.637

9.  Loss of Protease-Activated Receptor 4 Prevents Inflammation Resolution and Predisposes the Heart to Cardiac Rupture After Myocardial Infarction.

Authors:  Mikhail A Kolpakov; Xinji Guo; Khadija Rafiq; Liudmila Vlasenko; Bahman Hooshdaran; Rachid Seqqat; Tao Wang; Xiaoxuan Fan; Douglas G Tilley; John C Kostyak; Satya P Kunapuli; Steven R Houser; Abdelkarim Sabri
Journal:  Circulation       Date:  2020-06-03       Impact factor: 39.918

10.  Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population.

Authors:  Peter Garvin; Lennart Nilsson; John Carstensen; Lena Jonasson; Margareta Kristenson
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.